Luka Bojic

Mr. Luka Bojic

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
LBLuka Bojic
Luka Bojic
MPMina Peric
Mina Peric
JKJelena Karanović
Jelena Karanović
EMEmilija Milošević
Emilija Milošević
NGNatasa Kovacevic Grujicic
Natasa Kovacevic Grujicic
MMMilena Milivojevic
Milena Milivojevic
Background: Osteosarcoma (OS) is a highly aggressive bone malignancy with limited treatment options and poor prognosis. This exploratory study aimed to identify molecular subtypes of early-stage, treatment-naive OS to guide precise therapeutic strategies. Methods: We analyzed RNA-seq data obtained from tumor tissues from 102 OS patients using a non-negative matrix factorization algorithm (NMF) to classify the tumors into three subtypes: S1, S2, and S3. Differential gene expression was evaluated using DESeq2, followed by functional enrichment analysis with clusterProfiler and CancerHallmarks. The tumor microenvironment was assessed through ESTIMATE and CIBERSORT, and drug sensitivity was predicted using OncoPredict. SAOS-2 and MG63 cells, representing the S1 subtype, were used in the viability essays to determine the effect of hesperidin, a natural phenolic compound noted for its anti-cancer potential, alone and in combination with doxorubicin and 5-fluorouracil. Results: This study revealed three OS subtypes: S1 was enriched in cell cycle regulation, vesicular transport, and RNA metabolism while S2 and S3 were enriched in pathways related to extracellular matrix organization and protein translation, respectively. S1 displayed high tumor purity, significant chemoresistance, and overexpression of KIF20 A, correlating with poor prognosis. AURKB, a hesperidin target, was implicated in S1 pathogenesis. In vitro, hesperidin significantly reduced the viability of SAOS-2 and MG63 cells and enhanced doxorubicin efficacy. Conclusions: Our findings support the molecular subclassification of OS, emphasizing subtype-specific mechanisms of tumor progression and chemoresistance, with hesperidin offering potential as a therapeutic adjunct for high-risk OS patients.

13 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
LBLuka Bojic
Luka Bojic
MPMina Peric
Mina Peric
JKJelena Karanović
Jelena Karanović
EMEmilija Milošević
Emilija Milošević
NGNatasa Kovacevic Grujicic
Natasa Kovacevic Grujicic
MMMilena Milivojevic
Milena Milivojevic
Background: Osteosarcoma (OS) is a highly aggressive primary bone malignancy, for which treatment and prognosis remain unchanged for three decades. This study aimed to delineate molecular subtypes of early-stage, treatment-naive OS to improve molecular stratification and guide precise therapeutic strategies. Methods: The top 10% of the most variable genes of 102 OS tumour tissues were used in NMF to classify the tumours into three subtypes, S1, S2, and S3. Differential expression analysis was carried out using DESeq2 and functional enrichment analysis using clusterProfiler and CancerHallmarks. Tumor microenvironment composition was estimated through ESTIMATE and CIBERSORT, and drug sensitivity prediction using OncoPredict. NMF was also applied to RNA-seq data from 19 osteosarcoma cell lines and DEGs between the groups were correlated with the DEGs from patients' subtypes. SAOS-2, representing S1, was used in the viability assays to determine the effects of hesperidin, alone or in combination with doxorubicin and 5-fluorouracil. Results: S1 was enriched in cell cycle regulation, vesicular transport, and RNA metabolism with high tumor purity and high resistance to chemotherapeutics. S2 and S3 were enriched in extracellular matrix organization and protein translation pathways, respectively. KIF20A was significantly overexpressed gene indicating a poor prognosis of S1. AURKB, a hesperidin target, was found as an important gene for the pathogenesis of S1. Hesperidin significantly reduced SAOS-2 cell viability and enhanced the efficacy of doxorubicin. Conclusions: Our results offer a strong molecular basis for OS subclassification, highlighting subtype-specific mechanisms of tumour progression and chemoresistance. Our findings support the prospect of customized therapeutic approaches, with hesperidin being a promising co-adjuvant to improve the prognosis of high-risk OS patients.

24 February 2026 in Alternatives to Laboratory Animals
Verified
Journal Article
Closed access
JPJelena Pejić
Jelena Pejić
MMMilena Milivojevic
Milena Milivojevic
MSMarija Schwirtlich
Marija Schwirtlich
LBLuka Bojic
Luka Bojic
JSJasmina Stojkovska
Jasmina Stojkovska
MMMarija Mojsin
Marija Mojsin
We established a 3D model of human NT2/D1-derived early neural progenitor cells immobilised in alginate microfibres as a system for testing the neurotoxicity of energy drinks and their components, either alone, together, or in combination with alcohol. The in vitro system supports the retinoic acid-induced neurogenesis of NT2/D1 cells, and the proliferative capacity of the NT2/D1-derived early neural progenitor cells was maintained in the 3D environment. Cell cycle distribution and the expression of pluripotency markers ( SOX2 , OCT4 and NANOG ), early neural markers ( SOX3 , PAX6 and miR-219 ), and Cyclin D1 (a marker of neural commitment), showed profiles characteristic of early neural progenitors. Treatments with an energy drink and its major components (caffeine and taurine) — either alone, together, or in combination with alcohol — had different effects on the proliferative capacity of the NT2/D1-derived early neural progenitor cells in the 2D and 3D models. In the 2D-cultured cells, all treatments except for caffeine led to a significant decrease, while cells within the 3D model exhibited a significant increase after treatment with caffeine, or after combined treatment with energy drink and alcohol. Preliminary findings suggesting that there were no treatment effects on OCT4 and PAX6 protein expression in either model, should be further confirmed. This human cell-based 3D model could potentially represent a rapid and cost-effective system for assessing the acute and long-term neurotoxicity of various compounds.

18 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MNMirjana Novkovic
Mirjana Novkovic
AMAndjela Milicevic
Andjela Milicevic
EMEmilija Milošević
Emilija Milošević
LBLuka Bojic
Luka Bojic
JJJovana Jasnic
Jovana Jasnic
Snežana KojićSnežana Kojić
Snežana Kojić
Adult zebrafish efficiently regenerate skeletal muscle following different types of injury; however, the molecular programs involved in repair after extensive cryoinjury remain to be comprehensively characterized. Here, we explored the transcriptomic response of adult zebrafish skeletal muscle at 7 days post cryoinjury (dpci), a stage marked by ongoing tissue clearance, progenitor expansion, myogenic differentiation, and nascent myofiber formation, and compared it with phase-matched stab wound injury. Cryoinjury induced a broad transcriptional response, with 5,330 differentially expressed genes. Integrated enrichment and protein-protein interaction analyses revealed that, at 7 dpci, zebrafish skeletal muscle functions as an integrated regenerative system in which immune remodeling, progenitor expansion, myogenic differentiation, extracellular matrix reconstruction, mechanotransduction, biosynthetic adaptation, proteostasis, and intracellular trafficking operate simultaneously. In parallel, mature sarcomeric and oxidative metabolic programs were suppressed, consistent with ongoing tissue reconstruction and structural immaturity. Comparison with stab-wounded skeletal muscle revealed substantial transcriptional conservation, as 612 of 717 stab-wound-responsive genes (85%) were also differentially expressed after cryoinjury. Shared upregulated genes formed coherent functional modules related to proliferation, extracellular matrix organization and signaling, immune regulation, muscle differentiation, and protein processing. Thus, distinct injury modalities converge on a common regenerative program, while cryoinjury elicits a quantitatively broader transcriptional response. These findings support a conserved regenerative architecture of adult zebrafish skeletal muscle repair, in which interconnected biological modules act coordinately, with the breadth of transcriptional engagement reflecting regenerative demand.

1 January 2026
Verified
Journal Article
Open access
SLStefan Lazic
Stefan Lazic
LBLuka Bojic
Luka Bojic
AVAleksandra Vitkovac
Aleksandra Vitkovac
MSMilena Stevanovic
Milena Stevanovic
MMMilena Milivojevic
Milena Milivojevic
MSMarija Schwirtlich
Marija Schwirtlich
Oxygen deprivation, resulting from various pathological conditions, is a major cause of brain dysfunction throughout development and adulthood. Despite extensive preclinical research, much of it conducted in animal models, proposed neuroprotective treatments have largely failed in clinical trials. In the present study, using a human cell-based in vitro model of short-term hypoxic injury, we identified molecular alterations associated with impaired neural fate determination, ultimately resulting in a significant reduction in neuronal yield. RNA sequencing and functional enrichment analyses revealed that exposure to cobalt chloride (CoCl₂), a hypoxia-mimetic agent, induced a robust transcriptome response in NT2/D1 embryonal carcinoma stem cells, including metabolic dysfunction and increased expression of regulatory genes involved in multiple developmental processes and survival. More than 200 genes associated with neurogenesis and over 100 genes associated with synaptic signaling were significantly downregulated in early neural progenitor cells derived from CoCl₂-treated NT2/D1 cells. These findings were consistent with the observed morphological and immunocytochemical characteristics of the cells. Importantly, our study demonstrates that CoCl₂ selectively modulates the expression of genes involved in the differentiation of various cell populations, underscoring the need for further research to elucidate how this crucial cellular response to hypoxia shapes brain development and cognition.

26 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LBLuka Bojic
Luka Bojic
MPMina Peric
Mina Peric
IPIsidora Petrović
Isidora Petrović
MMMilena Milivojevic
Milena Milivojevic
Osteosarcoma is an aggressive malignancy whose treatment has changed little over the past decades, and outcomes remain poor. Although transcriptomic studies have provided insights into osteosarcoma biology, many include metastatic or post-treatment tumours, potentially obscuring transcriptional programs associated with intrinsic tumour aggressiveness. To address this limitation, we analysed transcriptomic profiles exclusively from treatment-naive, non-metastatic osteosarcoma patients to reconstruct prognostic transcriptional regulons associated with outcome. We identified distinct transcriptional programs associated with favourable and unfavourable outcomes. Tumours linked to poor prognosis were characterized by coordinated proliferative and metabolic transcriptional programs controlled by three regulatory hubs: CTCF, E2F4, and SP1, whose regulon enrichments showed strong associations with patient survival. To explore whether these regulatory networks could be pharmacologically modulated, molecular docking and dynamics simulations were performed, revealing potentially stable interactions between the hesperidin and the DNA-binding domains of these key transcription factors. Transcriptomic analysis of osteosarcoma cells treated with hesperidin revealed alterations in the identified regulons’ composition and decreased transcription factor activity. Together, these findings identify a transcriptional regulatory architecture underlying aggressive osteosarcoma, revealing novel prognostic biomarkers and suggesting that pharmacological modulation of master regulators such as CTCF, E2F4, and SP1, may represent a strategy to target transcriptional vulnerabilities in this malignancy.